Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengyu Zhu

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|May 13, 2025
Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databasesTao Wang, Zhiwei Cui, Yingyong Ou, et al.
Virology Journal|June 2, 2026
Post-marketing safety profile of bictegravir/emtricitabine/tenofovir alafenamide: a FAERS pharmacovigilance study with EudraVigilance validation and mechanistic investigation of pancreatitisYuxin Xie, Yawen Luo, Yinghua Chen, et al.
Hepato-Gastroenterology|December 2, 2014
Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancerHanqing Hu, Chaxiang Li, Shouwang Cai, et al.
Frontiers in Pharmacology|November 21, 2024
Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroupsYingyong Ou, Zhiwei Cui, Siyu Lou, et al.
Frontiers in Pharmacology|January 8, 2024
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) databaseFan Zou, Chengyu Zhu, Siyu Lou, et al.
BMC Psychiatry|January 20, 2025
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databasesSiyu Lou, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology|March 27, 2025
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting systemChengyu Zhu, Zhiwei Cui, Tingting Liu, et al.
Biosensors & Bioelectronics|September 25, 2019
Tailored monoclonal antibody as recognition probe of immunosensor for ultrasensitive detection of silk fibroin and use in the study of archaeological samplesJin Li, Yi Ouyang, Linshuai Liu, et al.
Frontiers in Endocrinology|July 21, 2023
Exercise improved bone health in aging mice: a role of SIRT1 in regulating autophagy and osteogenic differentiation of BMSCsChengyu Zhu, Haili Ding, Liang Shi, et al.
ACS Sensors|November 28, 2019
Ultrasensitive Electrochemical Immunosensor Reveals the Existence of Silk Products on the Maritime Silk RoadJin Li, Hailing Zheng, Yujie He, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|May 13, 2025
Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databasesTao Wang, Zhiwei Cui, Yingyong Ou, et al.
Virology Journal|June 2, 2026
Post-marketing safety profile of bictegravir/emtricitabine/tenofovir alafenamide: a FAERS pharmacovigilance study with EudraVigilance validation and mechanistic investigation of pancreatitisYuxin Xie, Yawen Luo, Yinghua Chen, et al.
Hepato-Gastroenterology|December 2, 2014
Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancerHanqing Hu, Chaxiang Li, Shouwang Cai, et al.
Frontiers in Pharmacology|November 21, 2024
Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroupsYingyong Ou, Zhiwei Cui, Siyu Lou, et al.
Frontiers in Pharmacology|January 8, 2024
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) databaseFan Zou, Chengyu Zhu, Siyu Lou, et al.
BMC Psychiatry|January 20, 2025
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databasesSiyu Lou, Zhiwei Cui, Yingyong Ou, et al.
Frontiers in Pharmacology|March 27, 2025
Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting systemChengyu Zhu, Zhiwei Cui, Tingting Liu, et al.
Biosensors & Bioelectronics|September 25, 2019
Tailored monoclonal antibody as recognition probe of immunosensor for ultrasensitive detection of silk fibroin and use in the study of archaeological samplesJin Li, Yi Ouyang, Linshuai Liu, et al.
Frontiers in Endocrinology|July 21, 2023
Exercise improved bone health in aging mice: a role of SIRT1 in regulating autophagy and osteogenic differentiation of BMSCsChengyu Zhu, Haili Ding, Liang Shi, et al.
ACS Sensors|November 28, 2019
Ultrasensitive Electrochemical Immunosensor Reveals the Existence of Silk Products on the Maritime Silk RoadJin Li, Hailing Zheng, Yujie He, et al.
Pageof 5